Neuren Pharmaceuticals Limited (ASX:NEU)

Neuren Pharmaceuticals Revenue

In the year 2024, Neuren Pharmaceuticals had annual revenue of 216.83M AUD, down -6.51%. Neuren Pharmaceuticals had revenue of 192.51M in the half year ending December 31, 2024, with 1,148.65% growth.

• Revenue: 216.83M
• Revenue Growth: -6.51%
• P/S Ratio: 7.22
• Revenue / Employee: 27.10M
• Employees: 8
• Market Cap: 1.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	216.83M	-15.11M	-6.51%
Dec 31, 2023	231.94M	216.53M	1,404.46%
Dec 31, 2022	15.42M	12.22M	382.23%
Dec 31, 2021	3.20M	2.48M	345.89%
Dec 31, 2020	717.00K	222.00K	44.85%